CN1651054A - Chinese medicine for treating brain disease - Google Patents

Chinese medicine for treating brain disease Download PDF

Info

Publication number
CN1651054A
CN1651054A CN 200410098678 CN200410098678A CN1651054A CN 1651054 A CN1651054 A CN 1651054A CN 200410098678 CN200410098678 CN 200410098678 CN 200410098678 A CN200410098678 A CN 200410098678A CN 1651054 A CN1651054 A CN 1651054A
Authority
CN
China
Prior art keywords
radix
rhizoma
chinese medicine
poria
salviae miltiorrhizae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410098678
Other languages
Chinese (zh)
Other versions
CN1279943C (en
Inventor
贺国政
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410098678 priority Critical patent/CN1279943C/en
Publication of CN1651054A publication Critical patent/CN1651054A/en
Application granted granted Critical
Publication of CN1279943C publication Critical patent/CN1279943C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine 'Naoguling' for treating encephalatrophy, chronic hydrocephalus, dizziness, osteoporosis, etc is prepared from 16 Chinese-medicinal materials including Chuan-xiong rhizome, red sage root, yam, walnut kernel, etc.

Description

A kind of Chinese medicine for the treatment of encephalopathy
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of encephalopathy.
Background technology
Progress along with society, people's life-span also increases gradually, and irreversible natural phenomena took place at 45 years old on descendant's physiology and changes in people's age, brain atrophy, the chronic hydrops of brain, slow-witted, the osteoporosis of hypomnesis, Light-headedness, brain disease thereupon, fractured easily by slight external force, this is a series of old illness.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine for the treatment of encephalopathy, prevent and treat brain atrophy, chronic hydrocephalus etc. to reach.
The Chinese medicine of treatment encephalopathy of the present invention, its prescription comprise following component (parts by weight): Rhizoma Ligustici 10-20, Radix Puerariae 10-30, Rhizoma Chuanxiong 12-20, Radix Salviae Miltiorrhizae 15-30, Rhizoma Dioscoreae 10-30, Fructus Corni 10-25, Semen Juglandis 20-30, Poria 10-40, Radix Rehmanniae Preparata 26-50, Rhizoma Coptidis 10-25, Radix Astragali 12-50, Rhizoma Alismatis 10-40, Cortex Moutan 10-30, Radix Glycyrrhizae 5-20, Radix Achyranthis Bidentatae 10-20, Cortex Eucommiae 10-30.
This Chinese medicine compound method: earlier each component is cleaned up, oven dry, levigation, capsule is made in sterilization.
The instructions of taking of Chinese medicine of the present invention: one time 5, three times on the one; One month one course of treatment.
In the Chinese medicine of the present invention's prescription: Radix Astragali QI invigorating; The Rhizoma Chuanxiong activating blood circulation; The Radix Salviae Miltiorrhizae promoting the circulation of blood calmness of enriching blood; The pain relieving of Rhizoma Ligustici sedation brain refreshing; Semen Juglandis is high-vegetable-plant and lecithin, the supplementing the brain nourishing brain cell; Rhizoma Dioscoreae, Fructus Corni, Radix Rehmanniae Preparata, Poria, Rhizoma Alismatis, Cortex Moutan the kidney invigorating, YIN nourishing strengthening kidney and tonifying bone; Rhizoma Coptidis is assisted the osseocolla hypertrophy, and prevention bone calcium takes off mistake; Radix Glycyrrhizae assists all medicines all to contain the kidney invigorating of calcium phosphorus, lecithin supplementing the brain.
The effect of the Chinese medicine of treatment encephalopathy of the present invention is as follows: old illness such as, osteoporosis slow-witted to brain atrophy, the chronic hydrops of brain, Light-headedness, brain disease are all effective in cure, and take for a long time and have no side effect, and have no drug resistance.
The specific embodiment
In one embodiment of the invention, the Chinese medicine of treatment encephalopathy of the present invention, the parts by weight of each component are in the prescription: Rhizoma Ligustici 10, Radix Puerariae 10, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 15, Rhizoma Dioscoreae 10, Fructus Corni 10, Semen Juglandis 20, Poria 10, Radix Rehmanniae Preparata 26, Rhizoma Coptidis 10, the Radix Astragali 12, Rhizoma Alismatis 10, Cortex Moutan 10, Radix Glycyrrhizae 5, Radix Achyranthis Bidentatae 10, the Cortex Eucommiae 10.
In another embodiment of the present invention, the Chinese medicine of treatment encephalopathy of the present invention, the parts by weight of each component are in the prescription: Rhizoma Ligustici 10, Radix Puerariae 10, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 15, Rhizoma Dioscoreae 10, Fructus Corni 10, Semen Juglandis 20, Poria 10, Radix Rehmanniae Preparata 26, Rhizoma Coptidis 10, the Radix Astragali 12, Rhizoma Alismatis 10, Cortex Moutan 10, Radix Glycyrrhizae 5, Radix Achyranthis Bidentatae 10, the Cortex Eucommiae 10.
In another embodiment of the present invention, the Chinese medicine of treatment encephalopathy of the present invention, the parts by weight of each component are in the prescription: Rhizoma Ligustici 10, Radix Puerariae 10, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 15, Rhizoma Dioscoreae 10, Fructus Corni 10, Semen Juglandis 20, Poria 10, Radix Rehmanniae Preparata 26, Rhizoma Coptidis 10, the Radix Astragali 12, Rhizoma Alismatis 10, Cortex Moutan 10, Radix Glycyrrhizae 5, Radix Achyranthis Bidentatae 10, the Cortex Eucommiae 10.
Capsule is made: clean up oven dry medicine-feeding levigation, sterilization, aseptic encapsulated; Oral: each 5, three times on the one.
Cure mainly and curative effect: old illness such as, osteoporosis slow-witted to brain atrophy, the chronic hydrops of brain, Light-headedness, brain disease are all effective in cure, and take for a long time and have no side effect, and have no drug resistance.
Clinical trial:
Case 1:
Li Wu, woman, 65 years old are because of chest pain, bronchopneumonia are spat in last sense fever, cough, take Chinese medicine and western medicine and take a turn for the better, spiritual then ambiguous, dizzy dizzy, walk unstablely, foot is unable, the time nausea and vomiting arranged, through CT examination is brain atrophy, slight hydrocephalus, and it is not good enough to take western medicine result.Agree that taking Chinese medicine of the present invention treats.
Chinese medicine preparation: the Radix Astragali 20, Thallus Laminariae (Thallus Eckloniae) 10, Radix Angelicae Sinensis 12, Radix Ginseng 15, Herba Hedyotidis Diffusae 30, Rabdosia rubescens 12, Herba Scutellariae Barbatae 20, Spica Prunellae 10, Fructus Ligustri Lucidi 10, Bulbus Lilii 10, Poria 12, the Rhizoma Atractylodis Macrocephalae 12, the Radix Stemonae 10, Sargassum 12, Carapax Trionycis 20, Gekko Swinhonis 20, Radix Glycyrrhizae 10, Fructus Xanthii 12, Herba Agrimoniae 12, Rhizoma Polygoni Cuspidati 12, Radix Bupleuri 10.
Instructions of taking: be decocted in water for oral dose a twice-daily.
Curative effect: adhere to taking half a year, cure.
Case 2:
Zhang Yuanming, the man, 56 years old, Tongxu Sun Ying people from village, dizzy dizzy gradually astasia over nearly 1 year, the time nausea and vomiting, headache, blurring of vision, xerophthalmia scheorma, dreaminess at night, irritability are arranged, go to this hospitalize.
Treatment prescription: Rhizoma Ligustici 10, Radix Puerariae 10, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 15, Rhizoma Dioscoreae 10, Fructus Corni 10, Semen Juglandis 20, Poria 10, Radix Rehmanniae Preparata 26, Rhizoma Coptidis 10, the Radix Astragali 12, Rhizoma Alismatis 10, Cortex Moutan 10, Radix Glycyrrhizae 5, Radix Achyranthis Bidentatae 10, the Cortex Eucommiae 10.
Instructions of taking: be decocted in water for oral dose a twice-daily.
Curative effect: adhere to taking half a year basic the healing.

Claims (3)

1, a kind of Chinese medicine for the treatment of encephalopathy is characterized in that, this Chinese medicine preparation comprises following component (parts by weight):
Rhizoma Ligustici 10-20, Radix Puerariae 10-30, Rhizoma Chuanxiong 12-20, Radix Salviae Miltiorrhizae 15-30, Rhizoma Dioscoreae 10-30, Fructus Corni 10-25, Semen Juglandis 20-30, Poria 10-40, Radix Rehmanniae Preparata 26-50, Rhizoma Coptidis 10-25, Radix Astragali 12-50, Rhizoma Alismatis 10-40, Cortex Moutan 10-30, Radix Glycyrrhizae 5-20, Radix Achyranthis Bidentatae 10-20, Cortex Eucommiae 10-30.
2, Naiguling Chinese medicine as claimed in claim 1, it is characterized in that the parts by weight of each component are in this Chinese medicine preparation: Rhizoma Ligustici 10, Radix Puerariae 10, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 15, Rhizoma Dioscoreae 10, Fructus Corni 10, Semen Juglandis 20, Poria 10, Radix Rehmanniae Preparata 26, Rhizoma Coptidis 10, the Radix Astragali 12, Rhizoma Alismatis 10, Cortex Moutan 10, Radix Glycyrrhizae 5, Radix Achyranthis Bidentatae 10, the Cortex Eucommiae 10.
3, Naiguling Chinese medicine as claimed in claim 1 or 2 is characterized in that this Chinese medicine is made into capsule.
CN 200410098678 2004-12-16 2004-12-16 Chinese medicine for treating brain disease Expired - Fee Related CN1279943C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410098678 CN1279943C (en) 2004-12-16 2004-12-16 Chinese medicine for treating brain disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410098678 CN1279943C (en) 2004-12-16 2004-12-16 Chinese medicine for treating brain disease

Publications (2)

Publication Number Publication Date
CN1651054A true CN1651054A (en) 2005-08-10
CN1279943C CN1279943C (en) 2006-10-18

Family

ID=34869521

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410098678 Expired - Fee Related CN1279943C (en) 2004-12-16 2004-12-16 Chinese medicine for treating brain disease

Country Status (1)

Country Link
CN (1) CN1279943C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101559152B (en) * 2009-05-19 2011-09-07 李桂华 Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
CN104398797A (en) * 2014-11-10 2015-03-11 李玉刚 Traditional Chinese medicine composition for treating children hydrocephalus and preparation method thereof
CN105796986A (en) * 2016-05-24 2016-07-27 包晓娜 Traditional Chinese medicinal composition for treating infant hydrocephalus

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474361B (en) * 2009-01-19 2011-03-16 河南百年康鑫药业有限公司 Chinese medicine for treating cerebropathy

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101559152B (en) * 2009-05-19 2011-09-07 李桂华 Chinese materia medica preparation for treating hydrocephalus and preparation method thereof
CN104398797A (en) * 2014-11-10 2015-03-11 李玉刚 Traditional Chinese medicine composition for treating children hydrocephalus and preparation method thereof
CN105796986A (en) * 2016-05-24 2016-07-27 包晓娜 Traditional Chinese medicinal composition for treating infant hydrocephalus

Also Published As

Publication number Publication date
CN1279943C (en) 2006-10-18

Similar Documents

Publication Publication Date Title
CN1124153C (en) Medicinal composition for restoring cardiac collaterals and its application
CN1169541C (en) Medicine for treating rheumatoid arthritis
CN1317027C (en) Chinese medicine for treating depression
CN1840126A (en) Chinese medicine for treating amblyopia and myopia
CN1298346C (en) Dynamic medicine for channels and collaterals and blood vessel
CN101161273B (en) A Chinese patent medicine for treating catagmat
CN101028481A (en) Medicinal liquor for treating hyperosteogency and koilorrhachic
CN102188560A (en) Traditional Chinese medicine for treating hyperlipidemia
CN101062368A (en) Chinese traditional medicine for treating cirrhosis ascites
CN104337974A (en) Drug for treating metrorrhagia and preparation method thereof
CN100421717C (en) A Chinese medicine for treating leukemia
CN1103223C (en) Chinese medicine for treating cholecystitis
CN1201691A (en) Medicine for curing encephalatrophy and preparation thereof
CN1130219C (en) Litholysizing bear gall powder
CN1279943C (en) Chinese medicine for treating brain disease
CN1698735A (en) Medicine for treating psoriasis
CN1296832A (en) Chinese medicine for treating psoriasis
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN1190218C (en) Chinese medicine for treating hyperosteogeny
CN101862402A (en) Chinese medicament for treating liver diseases
CN1907353A (en) Chinese traditional medicine preparation for treating chronic gastritis
CN1745826A (en) Chinese medicinal for treating heart disease
CN1178110A (en) Medicine for lung cancer
CN1270768C (en) Medicine for treating cold disease
CN101062236A (en) Astragalus radix pseudostell oral liquid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee